isoproterenol has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arai, N; Goshima, Y; Misu, Y; Misugi, K | 1 |
Hanani, M; Haskel, Y | 1 |
Aberle, NS; Haselton, JR; Muralikrishnan, D; Porter, JE; Ren, J; Wold, LE | 1 |
3 other study(ies) available for isoproterenol and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
Nanomolar L-dopa facilitates release of dopamine via presynaptic beta-adrenoceptors: comparative studies on the actions in striatal slices from control and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mice, an animal model for Par
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; In Vitro Techniques; Isoproterenol; Levodopa; Mice; Mice, Inbred C57BL; Parkinson Disease, Secondary; Receptors, Adrenergic, beta; Synapses | 1991 |
Inhibition of gastrointestinal motility by MPTP via adrenergic and dopaminergic mechanisms.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dopamine; Gastrointestinal Motility; Haloperidol; Isoproterenol; Male; Mice; Mice, Inbred BALB C; Pargyline; Phentolamine; Propranolol; Receptors, Adrenergic | 1994 |
Depressed contractile function and adrenergic responsiveness of cardiac myocytes in an experimental model of Parkinson disease, the MPTP-treated mouse.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Binding Sites; Caffeine; Calcium; Cell Size; Central Nervous System Stimulants; Disease Models, Animal; Dopamine Agents; Dose-Response Relationship, Radiation; Drug Interactions; Electric Stimulation; Extracellular Space; Heart; In Vitro Techniques; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocytes, Cardiac; Norepinephrine; Parkinsonian Disorders; Radioligand Assay; Sarcoplasmic Reticulum; Sympathomimetics; Time Factors | 2004 |